XML 66 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Investment Information - Net realized gains and losses (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Available for sale securities:        
Available for sale securities, gross gains on investment sales $ 104,733 $ 73,685 $ 515,086 $ 192,140
Available for sale securities, gross losses on investment sales (16,862) (30,561) (98,654) (77,498)
Equity securities, at fair value:        
Net realized gains (losses) on sales during the period 26,549 5,217 7,760 9,503
Net unrealized gains (losses) on equity securities still held at reporting date 33,562 (1,206) 3,682 58,562
Allowance for credit losses:        
Allowance for credit losses - investment related (229)   (10,578)  
Allowance for credit losses - underwriting related 351 0 (8,753) 0
Net impairment losses 0 (1,163) (533) (2,521)
Derivative instruments [1] 20,369 42,893 146,722 142,730
Other 7,303 1,335 (1,309) (8,703)
Net realized gains (losses) 280,499 61,355 470,127 322,368
Fixed maturities        
Available for sale securities:        
Change in fair value of assets and liabilities accounted for using the fair value option 34,115 (3,895) (25,370) 38,682
Allowance for credit losses:        
Allowance for credit losses - investment related 1,332 0 (4,763) 0
Other investments        
Available for sale securities:        
Change in fair value of assets and liabilities accounted for using the fair value option 61,622 (21,778) (67,608) (37,363)
Equity securities        
Available for sale securities:        
Change in fair value of assets and liabilities accounted for using the fair value option 4,048 (1,231) 5,803 9,449
Short-term investments        
Available for sale securities:        
Change in fair value of assets and liabilities accounted for using the fair value option $ 3,377 $ (1,941) $ (1,936) $ (2,613)
[1] See note 9 for information on the Company’s derivative instruments.